ClinConnect ClinConnect Logo
Search / Trial NCT05694611

Preterm Neonates Brain Ultrasound With CEUS and Elastography

Launched by TURKU UNIVERSITY HOSPITAL · Jan 20, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how well the brains of preterm babies are functioning as they approach their due date. Researchers want to see how blood flow and the elasticity (or stretchiness) of the brain tissue compare with results from a special type of brain scan called magnetic resonance imaging (MRI). To do this, they will use advanced ultrasound techniques that involve a contrast agent, which helps to visualize the blood flow better. The study is taking place at the Neonatal Intensive Care Unit (NICU) of Turku University Hospital and is currently looking for participants.

To be eligible for the study, babies must be preterm and scheduled for an MRI at their expected due date. However, certain conditions may exclude them from participating, such as having a known genetic condition, serious birth defects needing surgery, or issues related to their heart or lungs. Parents can expect their child to undergo both ultrasound and MRI tests, which are safe and commonly used in medical settings. This research aims to improve our understanding of brain health in preterm infants, which could lead to better care and outcomes for these vulnerable babies.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Preterm neonates attending brain MR-imaging at term
  • Exclusion Criteria:
  • Pre-known genetic disease
  • Difficult congenital malformations that need surgical treatment
  • Central nervous system tumors
  • Weight less than 2,5 kg during examination
  • Medical history of SonoVue hypersensitivity
  • Uncontrolled systemic hypertension
  • Systolic pulmonary artery pressure \> 90 mmHg
  • Unstable cardiovascular state

About Turku University Hospital

Turku University Hospital (TYKS) is a leading academic medical center located in Turku, Finland, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a key institution within the University of Turku, TYKS integrates cutting-edge medical education with state-of-the-art clinical services, offering a broad spectrum of specialized care. The hospital actively participates in clinical trials, facilitating the translation of scientific discoveries into practical treatments, and enhancing patient outcomes. With a multidisciplinary approach and a focus on collaboration, TYKS aims to contribute significantly to the global medical community through its rigorous research initiatives and commitment to patient-centered care.

Locations

Turku, Southwestern Finland, Finland

Patients applied

0 patients applied

Trial Officials

Tiina Laurikainen

Principal Investigator

Turku University Hospital

Riitta Parkkola

Study Director

Turku University Hospital

Vilhelmiina Parikka

Study Chair

Turku University Hospital

Jussi Hirvonen

Study Chair

Turku University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials